CLINICAL_TRIALS
trial_result
· 2018-10-19
Clinical Trial Update: Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia [Phase 3]
Summary
Long-term extension of lurasidone HCl (SM-13496) in schizophrenia completed; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma Co., Ltd. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2018-10-19